JP2003192696A5 - - Google Patents

Download PDF

Info

Publication number
JP2003192696A5
JP2003192696A5 JP2001377682A JP2001377682A JP2003192696A5 JP 2003192696 A5 JP2003192696 A5 JP 2003192696A5 JP 2001377682 A JP2001377682 A JP 2001377682A JP 2001377682 A JP2001377682 A JP 2001377682A JP 2003192696 A5 JP2003192696 A5 JP 2003192696A5
Authority
JP
Japan
Prior art keywords
seq
peptide
amino acid
acid sequence
mixture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2001377682A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003192696A (ja
JP4076766B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2001377682A priority Critical patent/JP4076766B2/ja
Priority claimed from JP2001377682A external-priority patent/JP4076766B2/ja
Priority to CA002389911A priority patent/CA2389911A1/en
Publication of JP2003192696A publication Critical patent/JP2003192696A/ja
Publication of JP2003192696A5 publication Critical patent/JP2003192696A5/ja
Application granted granted Critical
Publication of JP4076766B2 publication Critical patent/JP4076766B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2001377682A 2001-12-11 2001-12-11 発熱性外毒素に対する広スペクトルアンタゴニストおよびワクチン Expired - Fee Related JP4076766B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2001377682A JP4076766B2 (ja) 2001-12-11 2001-12-11 発熱性外毒素に対する広スペクトルアンタゴニストおよびワクチン
CA002389911A CA2389911A1 (en) 2001-12-11 2002-06-10 Broad spectruma antagonists and vaccines directed against pyrogenic exotoxins

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001377682A JP4076766B2 (ja) 2001-12-11 2001-12-11 発熱性外毒素に対する広スペクトルアンタゴニストおよびワクチン
CA002389911A CA2389911A1 (en) 2001-12-11 2002-06-10 Broad spectruma antagonists and vaccines directed against pyrogenic exotoxins

Publications (3)

Publication Number Publication Date
JP2003192696A JP2003192696A (ja) 2003-07-09
JP2003192696A5 true JP2003192696A5 (ru) 2005-07-21
JP4076766B2 JP4076766B2 (ja) 2008-04-16

Family

ID=32991630

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001377682A Expired - Fee Related JP4076766B2 (ja) 2001-12-11 2001-12-11 発熱性外毒素に対する広スペクトルアンタゴニストおよびワクチン

Country Status (2)

Country Link
JP (1) JP4076766B2 (ru)
CA (1) CA2389911A1 (ru)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8535672B2 (en) 2002-04-04 2013-09-17 Yissum Research Development Of The Hebrew University Of Jerusalem Broad-spectrum in-vivo effective superantigen toxin antagonists based on the interaction between CD28 and the superantigen and uses thereof

Similar Documents

Publication Publication Date Title
US20050163797A1 (en) Pharmaceutical composition comprising an antigen
ES2263408T1 (es) Prevencion y tratamiento de enfermedad amiloidogenica.
RU2009102815A (ru) Полипептиды из neisseria meningitidis
JP2009520758A5 (ru)
WO1997044349A9 (en) BLOCKING EXPRESSION OF VIRULENCE FACTORS IN $i(S. AUREUS)
RU97107853A (ru) Пептидная специфичность антител к мвр (миелиновому основному белку), содержащая его фармацевтическая композиция и способ лечения рассеянного склероза
BR0214363A (pt) Anticorpo, uso de um anticorpo, medicamento, método de fabricação de um medicamento e pacote farmacêutico para o tratamento de infecção
EP2030628B1 (en) A peptide for preventing or treating liver damage and its derivant and the use
WO2007121491A8 (en) Hcv vaccinations
JP2015524802A5 (ru)
RU2015106742A (ru) Композиции, содержащие химерные молекулы ospa и способы их применения
KR920004422A (ko) Hiv의 주요 중화 결정인자
JP2003192696A5 (ru)
EA200700178A1 (ru) Пептид, обладающий стресспротекторным действием, фармацевтическая композиция на его основе и способ ее применения
AU2005220156B2 (en) Peptides of IL1 beta and TNF alpha and method of treatment using same
WO2004022092A3 (en) Flagellin peptides as adjuvants for vaccines
US20100311656A1 (en) Treatment or prevention of respiratory viral infections with alpha thymosin peptides
EP1536833B1 (en) Vaccine against yersinia comprising one or two antibodies, one specific for yersinia pestis f1-antigen and the other one for yersina pestis v-antigen
WO2004094991A2 (en) Treatment or prevention of respiratory viral infections with alpha thymosin peptides
WO2015160501A1 (en) Particulate vaccine formulations for inducing innate and adaptive immunity
EP0241725A2 (en) Improvements in and relating to vaccines
JP4076766B2 (ja) 発熱性外毒素に対する広スペクトルアンタゴニストおよびワクチン
UA82097C2 (ru) Способ лечения или профилактики респираторной коронавирусной инфекции пептидом альфа-тимозина
Straub Studies on the suitability of alpha-hybrid interferon application in cattle
WO2002079240A3 (en) Intimins for the prevention or treatment of infections: i